Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Retained Earnings (2020 - 2025)

BioAtla's Retained Earnings history spans 6 years, with the latest figure at -$545.6 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 12.26% year-over-year to -$545.6 million; the TTM value through Dec 2025 reached -$545.6 million, down 12.26%, while the annual FY2025 figure was -$545.6 million, 12.26% down from the prior year.
  • Retained Earnings reached -$545.6 million in Q4 2025 per BCAB's latest filing, down from -$535.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$109.6 million in Q1 2021 to a low of -$545.6 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$352.5 million, with a median of -$372.7 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: plummeted 104.93% in 2021, then decreased 12.26% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$186.3 million in 2021, then plummeted by 57.15% to -$292.8 million in 2022, then tumbled by 42.17% to -$416.3 million in 2023, then decreased by 16.76% to -$486.0 million in 2024, then dropped by 12.26% to -$545.6 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Retained Earnings are -$545.6 million (Q4 2025), -$535.9 million (Q3 2025), and -$520.1 million (Q2 2025).